BridgeBio Pharma
BBIO
#1405
Rank
C$21.23 B
Marketcap
C$109.02
Share price
-2.75%
Change (1 day)
13.51%
Change (1 year)

BridgeBio Pharma (BBIO) - Total liabilities

Total liabilities on the balance sheet as of September 2026 : C$5.47 Billion

According to BridgeBio Pharma 's latest financial reports the company's total liabilities are C$5.47 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BridgeBio Pharma - Total liabilities on balance sheet (from 2018 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31C$4.12 B20.96%
2024-12-31C$3.41 B36.14%
2023-12-31C$2.50 B-1.16%
2022-12-31C$2.53 B5.88%
2021-12-31C$2.39 B215.16%
2020-12-31C$0.75 B273.51%
2019-12-31C$0.20 B70.46%
2018-12-31C$0.11 B-37.87%
2017-12-31C$0.19 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
OPKO Health
OPK
C$0.92 B-83.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
C$17.43 M-99.68%๐Ÿ‡บ๐Ÿ‡ธ USA